Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose

ATC	Name	B/G	Ingredients	Dosage	Form	Price
J01DC02	CEFUREX	G	Cefuroxime - 500mg	500mg	Tablet	490,503 L.L
J01DC02	CEFUZIME	G	Cefuroxime (axetil) - 500mg	500mg	Tablet, film coated	490,503 L.L
J01DC04	CECLOR MR	B	Cefaclor (monohydrate) - 500mg	500mg	Tablet, film coated, modified release	1,226,096 L.L
A12AA04	CALPEROS	G	Calcium (carbonate) - 500mg	500mg	Tablet	630,262 L.L
G01AF02	CANAGYN	G	Clotrimazole - 500mg	500mg	Tablet	302,365 L.L
L01BC06	CAPECITABINE ACCORD	G	Capecitabine - 500mg	500mg	Tablet, film coated	10,908,012 L.L
L01BC06	CAPECITABINE BIOGARAN	G	Capecitabine - 500mg	500mg	Tablet, coated	12,123,049 L.L
L01BC06	CAPECITABINE GP PHARM	G	Capecitabine - 500mg	500mg	Tablet, film coated	8,869,508 L.L
L01BC06	CAPECITABINE NEAPOLIS	G	Capecitabine - 500mg	500mg	Tablet, film coated	11,222,829 L.L
L01BC06	CAPECITABINE SPC	G	Capecitabine - 500mg	500mg	Tablet, film coated	12,665,771 L.L
L01BC06	CAPEDA	G	Capecitabine - 500mg	500mg	Tablet, film coated	4,927,423 L.L
J01DE01	CEFIPEX 500 BENTA	G	Cefepime (hydrochloride) - 500mg	500mg	Injectable solution	545,216 L.L
J05AB06	CYMEVENE	B	Ganciclovir (sodium) - 500mg	500mg	Injectable solution	1,726,838 L.L
N03AG01	CONVULEX RETARD	G	Sodium Valproate - 500mg	500mg	Tablet, prolonged release	423,310 L.L
L01XX05	CUREAML	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	1,228,272 L.L
L01XX05	CYTODROX	G	Hydroxycarbamide (or Hydroxyurea) - 500mg	500mg	Capsule	3,301,821 L.L
J01FA09	CLAREM 500	G	Clarithromycin - 500mg	500mg	Tablet, film coated	686,704 L.L
B03BA05	COBAL	G	Mecobalamine - 500mcg/ml	500mcg/ml	Injectable solution	1,128,828 L.L
B03BA01	COBAL	G	Vitamin B12 - 500mcg	500mcg	Tablet, coated	486,471 L.L
G03GA01	CHORIOMON	BioHuman	Human Chorionic Gonadotrophin - 5,000IU	5,000IU	Injectable lyophilised powder for solution+diluent	4,031,528 L.L
D06BA02	CREM-O-SULFA	G	Sulfathiazole - 5%	5%	Cream	202,216 L.L
D06BB03	CIVAR	G	Aciclovir - 5%	5%	Cream	507,972 L.L
C02CA04	CARDULAR	B	Doxazosin (mesylate) - 4mg	4mg	Tablet	755,239 L.L
C02CA04	CURCARD	G	Doxazosin (mesylate) - 4mg	4mg	Tablet	452,875 L.L
C01DX12	CORVASAL 4MG	B	Molsidomine - 4mg	4mg	Tablet	492,742 L.L
G03GA05	CINNAL-f	BioHuman	Follitropin alfa - 450IU/0.75ml	450IU/0.75ml	Injectable solution	7,372,177 L.L
L04AB04	CINNORA	BioTech	Adalimumab - 40mg/0.8ml	40mg/0.8ml	Injectable solution	14,817,734 L.L
L01EX07	CABOMETYX	B	Cabozantinib - 40mg	40mg	Tablet, film coated	424,098,997 L.L
C10AA07	CRESTOR	B	Rosuvastatin (calcium) - 40mg	40mg	Tablet, film coated	804,962 L.L
D10BA01	CONTRACNE ISOTRETINOINE	G	Isotretinoin - 40mg	40mg	Capsule, soft	3,043,803 L.L